-- 周四上午,亚洲股市在美国交易,美国存托凭证(ADR)大幅下跌,标普亚洲50指数下跌1.2%,至2766.6点。 北亚方面,领涨的股票包括旅游公司途牛(TOUR)和金融科技公司麻生(MAAS),分别上涨16.3%和15.9%。紧随其后的是教育公司51Talk在线教育集团(COE)和媒体公司凤凰新媒体(FENG),分别上涨5.5%和3.9%。 北亚方面,领跌的股票包括视频显示器制造商LG Display(LPL)和生物制药公司再鼎医药(ZLAB),分别下跌17%和5.3%。紧随其后的是半导体公司海迈科技(HIMX)和金融科技公司嘉银集团(JFIN),分别下跌5%和3.6%。 南亚股市中,仅有制药公司瑞迪博士实验室(Dr. Reddy's Laboratories,RDY)和电信运营商PLDT(PHI)上涨,分别上涨4.6%和0.2%。 南亚股市中,IT公司印孚瑟斯(Infosys,INFY)和威普罗(Wipro,WIT)领跌,分别下跌6.4%和4.7%。紧随其后的是科技集团Sea(SE)和电信运营商印尼电信(Telekomunikasi Indonesia,TLK),两家公司均下跌2.9%。
Related Articles
Update: Origin Energy Reports Lower March Quarter Production; Shares Fall 3%
(Updates to add stock movement in the headline and last paragraph)Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.The company reported commodity revenue of AU$1.86 billion for the quarter, down from AU$ 2.31 billion a year ago, per the filing.Origin Energy also said its electricity sales volume increased 4% from a year earlier amid "strong growth" in business volumes driven largely by the data-center sector.The company's shares fell 3% in recent Monday trade.
Alterity Therapeutics Secures US FDA Support for ATH434 Phase Three Program
Alterity Therapeutics (ASX:ATH) said it received positive feedback from a second type C meeting with the US Food and Drug Administration (FDA) on its planned phase three program for drug candidate ATH434, aimed at treating multiple system atrophy (MSA), according to a Monday filing with the Australian bourse.MSA is a progressive neurodegenerative disorder affecting autonomic and motor function with no approved disease-modifying therapies.The US FDA provided supportive written feedback on the program's chemistry, manufacturing, and controls, complementing earlier guidance from a separate type C meeting on clinical pharmacology and non-clinical development, the filing added.
Xinyuan Property Management's CFO Resigns
Xinyuan Property Management Service's (HKG:1895) chief financial officer, Wang Yong, has resigned, effective April 26, according to a Monday Hong Kong bourse filing.Wang stepped down to devote more time to personal commitments, the company said.The company said the resignation will not affect its normal operations, with Wang's duties to be reallocated internally on an interim basis.Xinyuan Property Management added that it is seeking a suitable replacement for the chief financial officer role.